Published: Vol 7, Iss 13, Jul 5, 2017 DOI: 10.21769/BioProtoc.2364 Views: 20836
Reviewed by: Antoine de MorreeAnonymous reviewer(s)
Protocol Collections
Comprehensive collections of detailed, peer-reviewed protocols focusing on specific topics
Related protocols
Murine Pancreatic Islets Transplantation under the Kidney Capsule
Tatiana Jofra [...] Manuela Battaglia
Mar 5, 2018 10590 Views
Murine Hair Follicle Derived Stem Cell Transplantation onto the Cornea Using a Fibrin Carrier
Mindy Call [...] Ursula Schlӧtzer-Schrehardt
May 20, 2018 5842 Views
Modeling NOTCH1 driven T-cell Acute Lymphoblastic Leukemia in Mice
Agnieszka A. Wendorff and Adolfo A. Ferrando
May 20, 2020 5509 Views
Abstract
Tumorigenicity refers to the ability of cultured cells to develop viable tumors in immune-deficient animals. The goal of this protocol is to illustrate tumorigenicity assay by subcutaneous tumor-cell-transplantation in nude mice. Target cells are transplanted to 6-week-old nude mice subcutaneously and the tumor growth is monitored over a period of observation or treatment. When tumor grows to a pre-determined size or by the end of the limited period, the nude mice will be euthanatized and the xenograft will be removed for further examination.
Keywords: TumorigenicityBackground
With high incidence and mortality, tumor is one of the leading causes of death and is a major public health problem. Extensive studies are conducted every year to explore tumor pathogenesis and anti-tumor therapy. In the process of cancer research, tumorigenicity assay in nude mice is a widely used experiment to monitor tumor growth in vivo (Giovanella et al., 1974). The most commonly used animal system for tumorigenicity assay is athymic nude mouse (Petricciani et al., 1973) where malignant cells can be transplanted either subcutaneously or subrenal-capsularly (van Meir, 1997). For cells with relatively low ability of tumorigenicity, take rate can be improved by irradiation (30-60 Gy) or implantation in Matrigel (Pretlow et al., 1991). Tumorigenicity assay provides a means of generating human cell derived tumor tissues for measurement of tumor cell malignancy and evaluation for anti-tumor drug efficacy.
Materials and Reagents
Equipment
Procedure
Data analysis
Notes
It is recommended to perform a small pilot study to determine the tumor take rate before the formal experiments. Additional cells and mice needed if the take rate is less than 100%.
Recipes
Acknowledgments
This work was funded by NSFC grants 81602641 to Dr. Xiaodi Zhao.
References
Article Information
Copyright
© 2017 The Authors; exclusive licensee Bio-protocol LLC.
How to cite
Readers should cite both the Bio-protocol article and the original research article where this protocol was used:
Category
Cancer Biology > Cancer stem cell > Animal models
Cell Biology > Cell Transplantation > Allogenic Transplantation
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.
Tips for asking effective questions
+ Description
Write a detailed description. Include all information that will help others answer your question including experimental processes, conditions, and relevant images.
Share
Bluesky
X
Copy link